{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:28:05Z","timestamp":1787372885214,"version":"build-2736575974"},"reference-count":40,"publisher":"MDPI AG","issue":"8","license":[{"start":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T00:00:00Z","timestamp":1787184000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"crossref","award":["WVA00748\/W2194\/W3194"],"award-info":[{"award-number":["WVA00748\/W2194\/W3194"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000199","name":"U.S. Department of Agriculture","doi-asserted-by":"crossref","award":["WVA00745\/NC1193"],"award-info":[{"award-number":["WVA00745\/NC1193"]}],"id":[{"id":"10.13039\/100000199","id-type":"DOI","asserted-by":"crossref"}]},{"award":["WVA00748\/W2194\/W3194"],"award-info":[{"award-number":["WVA00748\/W2194\/W3194"]}],"id":[{"id":"https:\/\/ror.org\/01na82s61","id-type":"ROR","asserted-by":"publisher"}]},{"award":["WVA00745\/NC1193"],"award-info":[{"award-number":["WVA00745\/NC1193"]}],"id":[{"id":"https:\/\/ror.org\/01na82s61","id-type":"ROR","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Int. J. Environ. Res. Public Health","IJERPH"],"abstract":"<jats:p>Background: Newly named Polyendocrine Metabolic Ovarian Syndrome (PMOS), previously Polycystic Ovary Syndrome (PCOS), affects women worldwide. The prevalence of PCOS is thought to range from 5 to 15% depending on the diagnostic criteria used. The 2023 International Evidence-Based Guidelines for the Assessment and Management of PCOS recognize the 2003 Rotterdam criteria as the gold standard diagnostic tool. The objective was to examine the global prevalence of PCOS across diagnostic criteria, phenotypes, geographical locations, races, and ethnicities by reviewing current research. Methods: Researchers searched PubMed, PsycINFO, and Scopus. The study included 27 articles. Results: Prevalence varies globally, ranging from 1.6% to 28.5% in North America. In Brazil, the prevalence was 30.4%. Europe showed rates ranging from 5.9% to 19.9%. In Asia, the prevalence ranged from 4.21% in rural India to 35.3% in the Kashmir Valley. Oceania showed a prevalence of 6.8% among Samoan women and 12% in Australian women. The Middle East ranged from 1.6% in Dubai to 48.5% in Pakistan. In Africa, the prevalence was 32.5% in Sudan. Conclusions: The study\u2019s findings highlight significant variations in the prevalence and phenotype distributions influenced by demographic factors and diagnostic criteria. Limitations include inconsistent diagnostic criteria, underrepresentation of geographical regions, and reliance on self-reported data, emphasizing the importance of using standardized diagnostic criteria and focused research.<\/jats:p>","DOI":"10.3390\/ijerph23081085","type":"journal-article","created":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T16:05:19Z","timestamp":1787241919000},"page":"1085","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Updated Overview of the Geographical Prevalence of Polycystic Ovary Syndrome by Diagnostic Criteria, Phenotypes, Race, and Ethnicity"],"prefix":"10.3390","volume":"23","author":[{"given":"Makenna J. O.","family":"Noland","sequence":"first","affiliation":[{"name":"School of Agriculture and Food Systems, Division of Land Grant Engagement, Davis College of Agriculture and Natural Resources, West Virginia University, Morgantown, WV 26506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6686-3891","authenticated-orcid":false,"given":"Melissa D.","family":"Olfert","sequence":"additional","affiliation":[{"name":"School of Agriculture and Food Systems, Division of Land Grant Engagement, Davis College of Agriculture and Natural Resources, West Virginia University, Morgantown, WV 26506, USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2026,8,20]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1093\/ejendo\/lvad096","article-title":"Recommendations from the 2023 international evidence-based guideline for the assessment and management of polycystic ovary syndrome","volume":"189","author":"Teede","year":"2023","journal-title":"Eur. J. Endocrinol."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1016\/S0140-6736(26)00717-8","article-title":"Polyendocrine metabolic ovarian syndrome, the new name for polycystic ovary syndrome: A multistep global consensus process","volume":"407","author":"Teede","year":"2026","journal-title":"Lancet"},{"key":"ref_3","doi-asserted-by":"crossref","unstructured":"Singh, S., Pal, N., Shubham, S., Sarma, D.K., Verma, V., Marotta, F., and Kumar, M. (2023). Polycystic ovary syndrome: Etiology, current management, and Future Therapeutics. J. Clin. Med., 12.","DOI":"10.3390\/jcm12041454"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1210\/er.2015-1104","article-title":"The Pathogenesis of Polycystic Ovary Syndrome (PCOS): The Hypothesis of PCOS as Functional Ovarian Hyperandrogenism Revisited","volume":"37","author":"Rosenfield","year":"2016","journal-title":"Endocr. Rev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.2337\/db20-0800","article-title":"Polycystic ovary syndrome and risk of type 2 diabetes, coronary heart disease, and stroke","volume":"70","author":"Zhu","year":"2021","journal-title":"Diabetes"},{"key":"ref_6","doi-asserted-by":"crossref","unstructured":"Christ, J.P., and Cedars, M.I. (2023). Current Guidelines for Diagnosing PCOS. Diagnostics, 13.","DOI":"10.3390\/diagnostics13061113"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1093\/ejendo\/lvaf062","article-title":"Should anti-M\u00fcllerian hormone be a diagnosis criterion for polycystic ovary syndrome? An in-depth review of pros and cons","volume":"192","author":"Pignatelli","year":"2025","journal-title":"Eur. J. Endocrinol."},{"key":"ref_8","doi-asserted-by":"crossref","unstructured":"Wolf, W.M., Wattick, R.A., Kinkade, O.N., and Olfert, M.D. (2018). Geographical Prevalence of Polycystic Ovary Syndrome as Determined by Region and Race\/Ethnicity. Int. J. Environ. Res. Public Health, 15.","DOI":"10.3390\/ijerph15112589"},{"key":"ref_9","doi-asserted-by":"crossref","unstructured":"Yasmin, A., Roychoudhury, S., Choudhury, A.P., Ahmed, A.B.F., Dutta, S., Mottola, F., Verma, V., Kalita, J.C., Kumar, D., and Sengupta, P. (2022). Polycystic Ovary Syndrome: An Updated Overview Foregrounding Impacts of Ethnicities and Geographic Variations. Life, 12.","DOI":"10.3390\/life12121974"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2841","DOI":"10.1093\/humrep\/dew218","article-title":"The prevalence and phenotypic features of polycystic ovary syndrome: A systematic review and meta-analysis","volume":"31","author":"Bozdag","year":"2016","journal-title":"Hum. Reprod."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"39.e1","DOI":"10.1016\/j.ajog.2023.04.010","article-title":"Incidence, prevalence, and trends in polycystic ovary syndrome diagnosis: A United States population-based study from 2006 to 2019","volume":"229","author":"Yu","year":"2023","journal-title":"Am. J. Obstet. Gynecol."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.ejogrb.2022.10.020","article-title":"Prevalence of polycystic ovary syndrome in European countries and USA: A systematic review and meta-analysis","volume":"279","author":"Chiaffarino","year":"2022","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"e0028","DOI":"10.1097\/pp9.0000000000000028","article-title":"Cross-sectional Study on the Knowledge and Prevalence of PCOS at a Multiethnic University","volume":"5","author":"Rao","year":"2020","journal-title":"Prog. Prev. Med. Progress."},{"key":"ref_14","doi-asserted-by":"crossref","unstructured":"Marchesan, L.B., Ramos, R.B., and Spritzer, P.M. (2021). Metabolic Features of Women With Polycystic Ovary Syndrome in Latin America: A Systematic Review. Front. Endocrinol., 12.","DOI":"10.3389\/fendo.2021.759835"},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0038-1676568","article-title":"The Prevalence of Metabolic Syndrome in the Different Phenotypes of Polycystic Ovarian Syndrome. A preval\u00eancia da s\u00edndrome metab\u00f3lica nos diferentes fen\u00f3tipos da s\u00edndrome do ov\u00e1rio polic\u00edstico","volume":"41","author":"Tavares","year":"2019","journal-title":"Rev. Bras. Ginecol. Obstet."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/s13098-021-00636-5","article-title":"Metabolic profile of women with PCOS in Brazil: A systematic review and meta-analysis","volume":"13","author":"Spritzer","year":"2021","journal-title":"Diabetol. Metab. Syndr."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ejogrb.2024.02.011","article-title":"Distribution and anthropometric characteristics of Rotterdam criteria-based phenotypic forms of Polycystic ovaries syndrome in Ukraine","volume":"295","author":"Tatarchuk","year":"2024","journal-title":"Eur. J. Obstet. Gynecol. Reprod. Biol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/cen.14063","article-title":"Characterization of metabolic changes in the phenotypes of women with polycystic ovary syndrome in a large Mediterranean population from Sicily","volume":"91","author":"Carmina","year":"2019","journal-title":"Clin. Endocrinol."},{"key":"ref_19","first-page":"100494","article-title":"Changes in the prevalence of polycystic ovary syndrome in China over the past decade","volume":"25","author":"Yang","year":"2022","journal-title":"Lancet Reg. Health West. Pac."},{"key":"ref_20","doi-asserted-by":"crossref","unstructured":"Bigambo, F.M., Wang, D., Zhang, Y., Mzava, S.M., Dai, R., and Wang, X. (2022). Current situation of menstruation and gynecological diseases prevalence among Chinese women: A cross-sectional study. BMC Women\u2019s Health, 22.","DOI":"10.1186\/s12905-022-01860-5"},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"794","DOI":"10.3349\/ymj.2022.63.8.794","article-title":"Age-Adjusted Prevalence and Characteristics of Women with Polycystic Ovarian Syndrome in Korea: A Nationwide Population-Based Study (2010\u20132019)","volume":"63","author":"Kim","year":"2022","journal-title":"Yonsei Med. J."},{"key":"ref_22","doi-asserted-by":"crossref","unstructured":"Park, Y.J., Shin, H., Jeon, S., Cho, I., and Kim, Y.J. (2021). Menstrual cycle patterns and the prevalence of premenstrual syndrome and polycystic ovary syndrome in korean young adult women. Healthcare, 9.","DOI":"10.3390\/healthcare9010056"},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"Goh, J.E., Farrukh, M.J., Keshavarzi, F., Yap, C.S., Saleem, Z., Salman, M., Ramatillah, D.L., Goh, K.W., and Ming, L.C. (2022). Assessment of prevalence, knowledge of polycystic ovary syndrome and health-related practices among women in klang valley: A cross-sectional survey. Front. Endocrinol., 13.","DOI":"10.3389\/fendo.2022.985588"},{"key":"ref_24","first-page":"1567","article-title":"Prevalence of Polycystic Ovary Syndrome among Malaysian Female University Staff","volume":"7","author":"Dashti","year":"2019","journal-title":"J. Midwifery Reprod. Health"},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"2209","DOI":"10.1111\/jog.14097","article-title":"Defining polycystic ovary syndrome phenotype in Vietnamese women","volume":"45","author":"Cao","year":"2019","journal-title":"J. Obs. Gynaecol. Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1002\/ijgo.13125","article-title":"Prevalence of polycystic ovary syndrome (PCOS) among reproductive age women from Kashmir valley: A cross-sectional study","volume":"149","author":"Ganie","year":"2020","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1002\/ijgo.12893","article-title":"Cross-sectional study of the prevalence of polycystic ovary syndrome in rural and urban populations","volume":"146","author":"Deswal","year":"2019","journal-title":"Int. J. Gynecol. Obstet."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"95","DOI":"10.18203\/2394-6040.ijcmph20175603","article-title":"A cross sectional study of polycystic ovarian syndrome among young women in Bhopal, Central India","volume":"5","author":"Gupta","year":"2018","journal-title":"Int. J. Community Med. Public Health"},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/ajo.12730","article-title":"Polycystic ovarian syndrome: Prevalence and impact on the wellbeing of Australian women aged 16\u201329 years","volume":"58","author":"Varanasi","year":"2018","journal-title":"Aust. N. Z. J. Obs. Gynaecol."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"e23106","DOI":"10.1002\/ajhb.23106","article-title":"Reproductive health, obesity, and cardiometabolic risk factors among Samoan women","volume":"30","author":"Maredia","year":"2018","journal-title":"AM. J. Hum. Biol."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Mousa, M., Al-Jefout, M., Alsafar, H., Kirtley, S., Lindgren, C.M., Missmer, S.A., Becker, C.M., Zondervan, K.T., and Rahmioglu, N. (2021). Prevalence of Common Gynecological Conditions in the Middle East: Systematic Review and Meta-Analysis. Front. Reprod. Health, 3.","DOI":"10.3389\/frph.2021.661360"},{"key":"ref_32","doi-asserted-by":"crossref","unstructured":"Mirza, F.G., Tahlak, M.A., Hazari, K., Khamis, A.H., and Atiomo, W. (2023). Prevalence of Polycystic Ovary Syndrome amongst Females Aged between 15 and 45 Years at a Major Women\u2019s Hospital in Dubai, United Arab Emirates. Int. J. Environ. Res. Public Health, 20.","DOI":"10.3390\/ijerph20095717"},{"key":"ref_33","first-page":"817","article-title":"Clinical, hormonal and metabolic factors associated with polycystic ovary syndrome among Pakistani women","volume":"45","author":"Memon","year":"2020","journal-title":"Rawal Med. J."},{"key":"ref_34","first-page":"231","article-title":"Prevalence of Polycystic Ovarian Syndrome with Associated Risk Factors and Impact on Well-Being among Women in Reproductive Aged (18\u201345) Years in Al-Madinah 2017","volume":"7","author":"Alraddadi","year":"2018","journal-title":"World J. Pharm. Res."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.eprac.2022.12.001","article-title":"Phenotype Prevalence and Health-Related Quality of Life of Lebanese Women With Polycystic Ovary Syndrome","volume":"29","author":"Naous","year":"2023","journal-title":"Endocr. Pract."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.18502\/sjms.v17i2.11455","article-title":"Knowledge, Prevalence and Practice of Polycystic Ovary Syndrome among Sudanese women in Khartoum State, Sudan: The need for health education","volume":"17","author":"Alfanob","year":"2022","journal-title":"Sudan. J. Med. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","unstructured":"Elasam, A.N., Ahmed, M.A., Ahmed, A.B.A., Sharif, M.E., Abusham, A., Hassan, B., and Adam, I. (2022). The prevalence and phenotypic manifestations of polycystic ovary syndrome (PCOS) among infertile Sudanese women: A cross-sectional study. BMC Womens Health, 22.","DOI":"10.1186\/s12905-022-01762-6"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1007\/s00404-024-07607-x","article-title":"Global prevalence of polycystic ovary syndrome in women worldwide: A comprehensive systematic review and meta-analysis","volume":"310","author":"Salari","year":"2024","journal-title":"Arch. Gynecol. Obstet."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"e250226","DOI":"10.1530\/JOE-25-0226","article-title":"Phenotypic variations in polycystic ovary syndrome: Metabolic risks and emerging biomarkers","volume":"267","author":"Ma","year":"2025","journal-title":"J. Endocrinol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 Statement: An Updated Guideline for Reporting Systematic Reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"}],"container-title":["International Journal of Environmental Research and Public Health"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1660-4601\/23\/8\/1085\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,8,22]],"date-time":"2026-08-22T04:18:14Z","timestamp":1787372294000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1660-4601\/23\/8\/1085"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8,20]]},"references-count":40,"journal-issue":{"issue":"8","published-online":{"date-parts":[[2026,8]]}},"alternative-id":["ijerph23081085"],"URL":"https:\/\/doi.org\/10.3390\/ijerph23081085","relation":{},"ISSN":["1660-4601"],"issn-type":[{"value":"1660-4601","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,8,20]]}}}